- Home
- ROIV vs SFD Comparison
ROIV vs SFD Comparison
Compare ROIV & SFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- SFD
- Stock Information
- Founded
- ROIV 2014
- SFD 1936
- Country
- ROIV United Kingdom
- SFD United States
- Employees
- ROIV N/A
- SFD N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- SFD
- Sector
- ROIV Health Care
- SFD
- Exchange
- ROIV Nasdaq
- SFD NYSE
- Market Cap
- ROIV 8.4B
- SFD 8.4B
- IPO Year
- ROIV N/A
- SFD 2025
- Fundamental
- Price
- ROIV $10.68
- SFD $21.10
- Analyst Decision
- ROIV Strong Buy
- SFD
- Analyst Count
- ROIV 8
- SFD 0
- Target Price
- ROIV $17.93
- SFD N/A
- AVG Volume (30 Days)
- ROIV 4.0M
- SFD 1.6M
- Earning Date
- ROIV 02-10-2025
- SFD 01-01-0001
- Dividend Yield
- ROIV N/A
- SFD N/A
- EPS Growth
- ROIV N/A
- SFD 14.48
- EPS
- ROIV N/A
- SFD 1.72
- Revenue
- ROIV $122,585,000.00
- SFD $14,188,000,000.00
- Revenue This Year
- ROIV $15.98
- SFD N/A
- Revenue Next Year
- ROIV N/A
- SFD N/A
- P/E Ratio
- ROIV N/A
- SFD $18.52
- Revenue Growth
- ROIV 140.04
- SFD N/A
- 52 Week Low
- ROIV $9.76
- SFD $19.10
- 52 Week High
- ROIV $13.06
- SFD $22.03
- Technical
- Relative Strength Index (RSI)
- ROIV 42.58
- SFD N/A
- Support Level
- ROIV $10.33
- SFD N/A
- Resistance Level
- ROIV $10.86
- SFD N/A
- Average True Range (ATR)
- ROIV 0.27
- SFD 0.00
- MACD
- ROIV 0.02
- SFD 0.00
- Stochastic Oscillator
- ROIV 29.96
- SFD 0.00
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About SFD SMITHFIELD FOODS INC
Smithfield is the largest hog producer and pork processor in the world, processing more than 27 million hogs in fiscal 2011, with a slaughter capacity of 110,000 hogs per day. Around 55% of all pork revenue comes from value-added packaged meats, which were the focus of previous acquisitions and central to the company's long-term strategy. The firm continues to expand its European operations.